Background

Content Library

Filter

Type
Topic
Product
  • Publication
  • Sep 8, 2015
Improving the prediction of absolute solvation free energies using the next generation OPLS force field
Shivakumar, et al. J. Chem. Theory Comput., 2012, 8(8), 2553-2558
  • Publication
  • Sep 8, 2015
On the Rational Design of Zeolite Clusters
Migues, et al. ACS Catal., 2015, 5, 2859-2865

Case Studies

Events

European Colloquium on Inorganic Reaction Mechanisms Event Materials Science
  • Sep 8th-11th, 2024
European Colloquium on Inorganic Reaction Mechanisms

Schrödinger is excited to be participating in the European Colloquium on Inorganic Reaction Mechanisms conference taking place on September 8th – 11th in Toulouse, France.

CAMX 2024 Event Materials Science
  • Sep 9th-12th, 2024
CAMX 2024

Schrödinger is excited to be participating in the CAMX 2024 taking place on September 9th – 12th in San Diego, California.

2024 International Elastomer Conference Event Materials Science
  • Sep 9th-12th, 2024
2024 International Elastomer Conference

Schrödinger is excited to be participating in the 2024 International Elastomer Conference taking place on September 9th – 12th in Pittsburgh, Pennsylvania.

Publications

Webinars

Computationally-Guided Drug Formulation Webinar Series Webinar Life Science
  • Sep 11th – Nov 6th, 2024
Computationally-Guided Drug Formulation Webinar Series

Join us this fall for Schrödinger’s Drug Formulation Webinar Series – five webinars in which we will explore how the latest computational modeling tools are impacting the various steps in the pharmaceutical formulation process.

Case-study_MALT1-inhibitor Webinar Life Science
  • Sep 18, 2024
Schrödinger デジタル創薬セミナー: Into the Clinic~計算化学がもたらす創薬プロセスの変貌~第12回

Accelerated In silico Discovery of SGR-1505: a Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-cell Malignancies

Case-study_MALT1-inhibitor Webinar Life Science
  • Sep 12, 2024
Accelerated in silico discovery of SGR-1505: A potent MALT1 allosteric inhibitor for the treatment of mature B-cell malignancies

We are delighted to bring you another webinar in our series Stories of Drug Hunting in a Digital Age – featuring conversations with veteran drug hunters who share their unique drug discovery stories, from idea to development candidate.

White Papers

dark theme background

Latest insights from Extrapolations blog

With FEP+, “The Experiment is the Limit.”
With FEP+, “The Experiment is the Limit.”

Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.

Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods (FEP)
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods

The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.

Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In

We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.

Training & Resources

Online certification courses

Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.

Free learning resources

Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.